Almirid-Cripar®



Product description

The active substance in Almirid-Cripar is the hydrogenated ergot alkaloid a-dihy­droergocryptine methane sulfonate, which has high affinity for dopamine receptors. alpha-Dihydroergocryptine methane sulfonate is a selective D2 receptor agonist and a partial D1 receptor agonist, and in vivo it has no activity on serotonergic or adre­nergic receptors.

 

Indication

For the treatment of shaking palsy (idiopathic Parkinson's disease) in patients without fluctuations in their clinical picture, either as monotherapy or in combination with levodopa (with or without a decarboxylase inhibitor).

 

 

Product category

neurology

Last update: September 16, 2015 at 03:10 PM